Coral Laboratories Limited (BOM:524506)

India · Delayed Price · Currency is INR

422.95

+1.05 (0.25%)

At close: Apr 16, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceutical Formulations	1.15B	836.60M	781.19M	756.11M	965.67M
Pharmaceutical Formulations Growth	37.47%	7.09%	3.32%	-21.70%	36.82%
Total	1.15B	836.60M	781.19M	756.11M	965.67M
Total Growth	37.47%	7.09%	3.32%	-21.70%	36.82%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Ethopia	247.24M	157.72M	32.23M	95.76M	296.90M
Ethopia Growth	56.76%	389.30%	-66.34%	-67.75%	432.67%
India	219.04M	200.03M	275.04M	149.21M	175.61M
India Growth	9.50%	-27.27%	84.33%	-15.04%	-18.48%
Rest of World	665.51M	463.24M	471.67M	487.26M	479.54M
Rest of World Growth	43.66%	-1.79%	-3.20%	1.61%	16.58%
Total	1.13B	820.99M	778.94M	732.23M	952.05M
Total Growth	37.86%	5.40%	6.38%	-23.09%	39.49%

Source: S&P Global Market Intelligence.